Surgery Websites
T32 Surgical Oncology »  Faculty Mentors »  Health Services & Implementation Science »  Maren Scheuner-Purcell, MD, MPH
Maren Scheuner-Purcell, MD, MPH

Maren Scheuner-Purcell, MD, MPH

  • Professor, Clinical Pediatrics; Medical Director Cancer Genetics, HDCCC

Contact Information

4150 Clement Street, #1B-1
San Francisco, CA 94121
Phone: 415-476-3362
[email protected]
Open Popup
  Dept or School    
  End Date    
  • UCLA Intercampus Medical Genetics Training Program, Los Angeles, CA
  • Medical Genetics
  • 06/1994
  • UCLA-Olive View Internal Medicine Training Program, Sylmar, CA
  • Internal Medicine
  • 06/1991
  • UCLA, Los Angeles, CA
  • MPH
  • Public Health
  • 06/1984
  • UC Riverside, Riverside, CA
  • BS
  • Biology
  • 05/1982
  • UCLA, Los Angeles, CA
  • MD
  • Medicine
  • 06/1988
  • Dr. Scheuner is an internist and medical geneticist. She is a Clinical Professor in the UCSF Department of Medicine, Division of Hematology-Oncology and in the UCSF Department of Pediatrics, Division of Medical Genetics. She is the Chief of Genomic Medicine with the Veterans Integrated Service Network 21, Clinical Resource Hub.

    Dr. Scheuner is a health services resercher and implementation scientist. Her research activities focus on the integration of genetic services and genetic testing into clinical practice. Areas of focus include: genomic medicine care coordination and equity, delivery models for clinical genetic services, outcomes of precision medicine and their value, clinical validity and utility of family history tools in risk assessment and disease prevention, and genetic testing technologies and communication.

    Dr. Scheuner is a founding fellow of the American College of Medical Genetics and Genomics (ACMG). From 2013-2019 she served on the ACMG Board of Directors and was Vice President for Clinical Genetics. Since 2003, she has served as the ACMG representative to the national Blue Cross Blue Shield Association's Medical Advisory Panel. Since 2014 she has served as Editor for the journal Genetics in Medicine.
      Confired By    
  • Faculty Development Award in Precision Medicine and Health Services Research
  • UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS) Program
  • 2019
  • Field-based Meeting Award, VA Precision Medicine Research Conference
  • VA Office of Research and Development, Health Services Research & Development Service
  • 2016
  • Most read manuscripts published on topic of cardiovascular risk factors
  • American Heart Association, Circulation Cardiovascular Genetics
  • 2011
  • Silver Medal Award
  • RAND Corporation
  • 2008
  • Career Development Program in Public Health Research and Practice, Genetics and Disease Prevention
  • Centers for Disease Control and Prevention
  • 2002 - 2005
  • Dr. Scheuner-Purcell is an internist and clinical geneticist with research interests in health services and implementation research, addressing family health history, screening for Lynch syndrome (the most common cause of hereditary colon cancer), and strategies for improving communication of genetic test results between the laboratory and ordering clinician. As former Chief of Medical Genetics at the VA Greater Los Angeles Healthcare System, Dr Scheuner-Purcell has mentored many genetic fellows and residents.

    Trainees can participate in projects examining care coordination to facilitate precision medicine services in the Veterans Health Administration, as well as recruitment of veteran's for the WISDOM study.

    Data provided by UCSF Profiles, powered by CTSI
    1. Esserman L, Eklund M, Veer LV, Shieh Y, Tice J, Ziv E, Blanco A, Kaplan C, Hiatt R, Fiscalini AS, Yau C, Scheuner M, Naeim A, Wenger N, Lee V, Heditsian D, Brain S, Parker BA, LaCroix AZ, Madlensky L, Hogarth M, Borowsky A, Anton-Culver H, Kaster A, Olopade OI, Sheth D, Garcia A, Lancaster R, Plaza M. The WISDOM study: a new approach to screening can and should be tested. Breast Cancer Res Treat. 2021 Oct; 189(3):593-598. View in PubMed
    2. Lin GA, Trosman JR, Douglas MP, Weldon CB, Scheuner MT, Kurian A, Phillips KA. Influence of payer coverage and out-of-pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings. J Genet Couns. 2022 02; 31(1):130-139. View in PubMed
    3. Galbraith LN, Preys CL, Rehm HL, Scheuner MT, Hajek C, Green RC, Christensen KD. Primary care providers' responses to unsolicited Lynch syndrome secondary findings of varying clinical significance. Genet Med. 2021 10; 23(10):1977-1983. View in PubMed
    4. Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Arnold N, Aronson KJ, Arun BK, Augustinsson A, Azzollini J, Barrowdale D, Baynes C, Becher H, Bermisheva M, Bernstein L, Bialkowska K, Blomqvist C, Bojesen SE, Bonanni B, Borg A, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldés T, Caligo MA, Campa D, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chung WK, Claes KBM, Clarke CL, GEMO Study Collaborators, EMBRACE Collaborators, Collée JM, Conroy DM, Czene K, Daly MB, Devilee P, Diez O, Ding YC, Domchek SM, Dörk T, Dos-Santos-Silva I, Dunning AM, Dwek M, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Flyger H, Fostira F, Friedman E, Fritschi L, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, Garcia-Barberan V, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA, Gehrig A, Georgoulias V, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hart SN, He W, Hogervorst FBL, Hollestelle A, Hopper JL, Horcasitas DJ, Hulick PJ, Hunter DJ, Imyanitov EN, KConFab Investigators, HEBON Investigators, ABCTB Investigators, Jager A, Jakubowska A, James PA, Jensen UB, John EM, Jones ME, Kaaks R, Kapoor PM, Karlan BY, Keeman R, Khusnutdinova E, Kiiski JI, Ko YD, Kosma VM, Kraft P, Kurian AW, Laitman Y, Lambrechts D, Le Marchand L, Lester J, Lesueur F, Lindstrom T, Lopez-Fernández A, Loud JT, Luccarini C, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Mebirouk N, Meindl A, Miller A, Milne RL, Montagna M, Nathanson KL, Neuhausen SL, Nevanlinna H, Nielsen FC, O'Brien KM, Olopade OI, Olson JE, Olsson H, Osorio A, Ottini L, Park-Simon TW, Parsons MT, Pedersen IS, Peshkin B, Peterlongo P, Peto J, Pharoah PDP, Phillips KA, Polley EC, Poppe B, Presneau N, Pujana MA, Punie K, Radice P, Rantala J, Rashid MU, Rennert G, Rennert HS, Robson M, Romero A, Rossing M, Saloustros E, Sandler DP, Santella R, Scheuner MT, Schmidt MK, Schmidt G, Scott C, Sharma P, Soucy P, Southey MC, Spinelli JJ, Steinsnyder Z, Stone J, Stoppa-Lyonnet D, Swerdlow A, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Teulé A, Thull DL, Tischkowitz M, Toland AE, Torres D, Trainer AH, Truong T, Tung N, Vachon CM, Vega A, Vijai J, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Wolk A, Yadav S, Yang XR, Yannoukakos D, Zheng W, Ziogas A, Zorn KK, Park SK, Thomassen M, Offit K, Schmutzler RK, Couch FJ, Simard J, Chenevix-Trench G, Easton DF, Andrieu N, Antoniou AC. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 May 14; 12(1):2986. View in PubMed
    5. Scheuner MT, Douglas MP, Sales P, Ackerman SL, Phillips KA. Laboratory business models and practices: implications for availability and access to germline genetic testing. Genet Med. 2021 09; 23(9):1681-1688. View in PubMed
    6. View All Publications


    Site Directory